Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3876_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
10 Мб
Скачать
☆
5.4 Perioperative Management
https://t.me/medicina_free
5.4.5.9 Short Stay EVAR
Studies
Shaw etal. [106] aimed to examine evidence for the safety and utility of a short stay care pathway for EVAR.Inclusion criteria were asymptomatic patients, favourable anatomy, patient consent, technical success, able to mobilise post-operatively, trans­fer time to hospital if readmission <60min, and adult observer for rst 24h. From ve suitable studies, 450 (75%) patients were successfully discharged the same or next day after EVAR.Complications most often occurred within 3h of surgery, and major complications requiring intensive treatment unit admission occurred within 6h. Readmission rates were 0–5% for those discharged early, with no difference in 30-day readmission. Early discharge led to a statistically signicant cost saving of £13,360 (LOS 4days) to £9844 (LOS 1day).
The objective of a retrospective, single-center cohort study presented by Montross etal. [107] was to assess the possibility of developing a preoperative prole to select potential candidates for ambulatory admission with early discharge (≤6h after sur­gery) or to have EVAR performed in a free-standing ambulatory surgery center (ASC). Analysis of 272 elective endovascular aortic aneurysm repairs (EVAR) cases revealed that failed percutaneous EVAR (odds ratio, 2.37) and percutaneous EVAR performed outside of the manufacturer’s instructions for use (odds ratio,
2.84) were risk factors associated with ambulatory EVAR ineligibility. Early dis­charge after EVAR is possible in more than one-half of patients, permitting ambula­tory hospital admission and discharge. However, preoperative proling is not yet sufcient to endorse performing EVAR at free-standing ambulatory surgery centers at this time.
147
5.4.6 Ruptured Abdominal Aortic Aneurysm (rAAA)
5.4.6.1 Anaesthesia forEVAR
The ESVS guidelines [1] recommend:
• Recommendation 67: Local anaesthesia should be considered as the anaesthetic
modality of choice for endovascular repair of ruptured abdominal aortic aneu-
rysm whenever tolerated by the patient. (Class IIa; Level B)
Studies
Mouton et al. [108] reported on 3101 patients with rAAA captured in the UK National Vascular Registry. 2306 underwent on open procedure and 795 had EVAR (local anaesthesia, LA, n = 319; general anaesthesia, GA, n = 435; regional
148
https://t.me/medicina_free
5 Abdominal Aortic Aneurysm (AAA)
anaesthesia, RA, n=41). Overall, 56 of 72 hospitals (78%) offered LA for EVAR of rAAA.Patients who had surgery under LA had a lower in-hospital mortality rate than patients who received GA (18.5% vs 28.0%), and this was unchanged after adjustment for factors known to inuence survival (adjusted hazard ratio 0·62; P=0·003). Median hospital stay and postoperative morbidity from other complica­tions were similar. The study provided further evidence of the benet of LA for patients undergoing emergency EVAR for rAAA.
Using the Vascular Quality Initiative database, Faizer etal. [109] compared LA vs GA in EVAR for rAAA.Among 3330 patients with rAAA, 226 (6.8%) under­went EVAR in LA and 1510 (45.3%) underwent EVAR in GA.Hospital mortality rates were signicantly lower with EVAR in LA compared with EVAR in GA (15.5% vs. 23.3%; p=0.04). Patients undergoing EVAR who were <75years old and those without preoperative hypotension had the greatest survival benet from LA compared with GA.
Propensity score matching techniques were used by Bennett etal. [110] to com­pare the 30-day postoperative outcomes of patients from the 2007 to 2015 American College of Surgeons National Surgical Quality Improvement Program database who underwent endovascular repair of rAAA under locoregional vs general anaesthesia. 130 general anaesthesia patients were well matched with their locoregional anaes­thesia counterparts. The 30-day postoperative mortality rates for patients in the matched cohort were 14.6% for patients in the locoregional anaesthesia group com­pared with 29.2% for patients in the general anaesthesia group (P=.002).
The rst meta-analysis focusing on the effect of the anaesthesia modality on perioperative mortality in endovascular repair of ruptured abdominal aortic aneu­rysms was performed by Deng etal. [111]. A total of eight studies were included in this analysis. Three different pooled analyses of the data from the included studies revealed robust results that endovascular repair of ruptured abdominal aortic aneu­rysms (REVAR) under locoregional anesthesia is associated with a lower 30-day/ in-hospital mortality than REVAR under general anaesthesia. However, because the included studies may have had some observation bias, further randomized con­trolled trials are warranted to validate these results. Despite the perioperative sur­vival benet of REVAR under LA vs GA observed, clinicians must exercise caution when adopting this procedure. LA was associated with some potential disadvan­tages, including patient anxiety, discomfort, and movement artifacts caused by pain or un-intubated respiration. In addition, awake patients might have a limited toler­ance of time on the operating table, which increases the urgency of the REVAR.These factors may result in inaccurate or incorrect deployment of the stent grafts.
5.4 Perioperative Management
https://t.me/medicina_free
149
5.4.6.2 Access Type forEVAR inRuptured Abdominal Aortic Aneurysms
Studies
Cheng etal. [112] identied 1206 patients with EVAR for rAAA in the VQI data­base. 739 (61.3%) EVARs were performed by percutaneous access, 416 (34.5%) by open access, and 51 (4.2%) by failed percutaneous that converted to open access. Percutaneous access, compared with open access and failed percutaneous access, respectively, had the shortest operative time (min, median) (111 vs. 138 vs. 180, P<0.001) and was most often performed under local anesthesia (16.7% vs. 5% vs.
9.8%, P<0.001). Multivariable analysis did not show access type to have a signi­cant effect on cardiac complications, pulmonary complications, any complications, return to the operating room, or perioperative mortality. However, open access was independently associated with a prolonged length of stay (P=0.012). Access during these emergent procedures should be based on surgeon preference and experience.
5.4.6.3 Permissive Hypotension
The ESVS guidelines [1] recommend:
• Recommendation 66: In patients with ruptured abdominal aortic aneurysm, a
policy of permissive hypotension, by restricting uid resuscitation, is recom-
mended in the conscious patient. (Class I; Level B)
Studies
In the management of people with rAAA, controlled hypotension resuscitation aims to replace sufcient uid to maintain the blood pressure between 50 and 100mmHg during the preoperative and intra-operative period. The controlled hypotension strategy avoids large volumes of crystalloid replacement. It may help to prevent blood loss by avoiding: the clot disruption caused by a rapid increase in systolic blood pressure; the dilution of clotting factors, platelets, and brinogen; and the temperature decrease that inhibits enzyme activity involved in platelet and clotting factor function. The principle of controlled hypotension is widely adopted for peo­ple with trauma and has been applied for people with rAAA.A Cochrane Review [113] found no RCTs that compared controlled hypotension and normotensive resuscitation strategies in the management of haemorrhagic shock in patients with ruptured abdominal aortic aneurysm that assessed mortality, presence of coagulopa­thy, intensive care unit length of stay, and the presence of myocardial infarct and renal failure. In conclusion, high quality studies that evaluate the best strategy for managing haemorrhagic shock in ruptured abdominal aortic aneurysms are required.
NICE published an evidence review on permissive hypotension during transfer of people with rAAA to regional vascular services [114]. Although there was a lack
150
https://t.me/medicina_free
5 Abdominal Aortic Aneurysm (AAA)
of evidence on permissive hypotension during transfer of people with ruptured AAA, the committee noted that a recommendation in the clinical guideline on assessment and management of major trauma (NICE guideline NG39) recom­mended the use of restrictive approaches to volume resuscitation in this population. They agreed that the rationale underpinning the use of restrictive uid rescuscitation in people after major trauma was applicable to people with ruptured AAA, as both groups experience profuse bleeding. As a result, the committee considered it rea­sonable to adapt the recommendation from NICE guideline NG39 so it can be used within the context of AAA.Excessive uid resuscitation can dilute clotting factors, cause hypocalcaemia and reduce a patient’s body temperature. The committee agreed that a potential benet of a permissive hypotensive resuscitation strategy is that it can make surgery easier by reducing the size of haematomas. Furthermore, patients will retain the ability to form clots, making postoperative manage­ment easier.
5.4.6.4 Aortic Occlusion Balloon
The ESVS guidelines [1] recommend:
• Recommendation 68: Aortic balloon occlusion for proximal control should be
considered in haemodynamically unstable ruptured abdominal aortic aneurysm
patients undergoing open or endovascular repair. (Class IIa; Level C)
Studies
Karkos etal. [115] aimed to investigate whether the use of aortic occlusion balloon (AOB) has an impact on mortality of patients undergoing endovascular repair of ruptured abdominal aortic aneurysms. Included in this meta-analysis were 39 eli­gible studies reporting 1277 patients. The pooled perioperative mortality was
21.6%. A total of 200 patients required AOB with an estimated pooled proportion of
14.1%. There was a statistically signicant negative correlation between AOB and mortality and a positive effect of hemodynamic instability on mortality. In practical terms, mortality was signicantly higher in studies with a higher proportion of hemodynamically unstable patients and lower in studies with a higher rate of AOB use. The study provided meta-analytical evidence that the use of an AOB in unstable rAAA patients undergoing endovascular repair may improve the results.
5.4.6.5 Abdominal Compartment Syndrome
The ESVS guidelines [1] recommend:
• Recommendation 71: In all patients undergoing open or endovascular treatment
for ruptured abdominal aortic aneurysm, monitoring of intra-abdominal pressure
5.4 Perioperative Management
https://t.me/medicina_free
151
for early diagnosis and management of intra-abdominal hypertension/abdominal
compartment syndrome is recommended. (Class I; Level B)
• Recommendation 72: In the presence of abdominal compartment syndrome after
open or endovascular treatment of ruptured abdominal aortic aneurysm, decom-
pressive laparotomy is recommended. (Class I; Level B)
• Recommendation 73: In the management of open abdomen following decom-
pression for abdominal compartment syndrome after open or endovascular treat-
ment of ruptured abdominal aortic aneurysm, vacuum assisted closure system
should be considered. (Class IIa; Level B)
Studies
A population-based Swedish study described the incidence, treatment, and outcome of abdominal compartment syndrome (ACS) after rAAA [116]. ACS developed in
6.8% after OR versus 6.9% after EVAR.In the rAAA group, the 30-day mortality rate with ACS was 42.4%. Without ACS, the 30-day mortality rate was 23.5%. There was no difference in mortality between EVAR and OR among those who developed ACS.After rAAA and OR the mortality rate was 37.5% at 30days, the corresponding mortality rates after EVAR were 50% at 30 days. In all, approxi­mately 14.9% (10.7% prophylactic treatment + 4.2% after decompression laparot­omy) required open abdomen treatment after rAAA repair. Thus, ACS is a devastating complication after rAAA repair, regardless of whether an open or endo­vascular technique is used. This knowledge is particularly important given the fact that ACS developed as often after EVAR as after OR (although prophylactic open abdomen treatment was common after OR).
In a second Swedish study, during 2008–2015, 120 of 8765 patients undergoing surgery for infrarenal AAA developed postoperative ACS (1.4%). Among 1718 repairs for rAAA and 7009 repairs for iAAA, the risks of ACS were 45/1212 (3.7%) after OR for rAAA, 38/506 (7.5%) after EVAR for rAAA, 307/2859 (1.0%) after OR for iAAA, and 7/4150 (0.2%) after EVAR for iAAA [117]. The duration of intraabdominal hypertension before treatment predicted the need for renal replace­ment therapy. This emphasises the need to focus on prevention, through careful monitoring of intra-abdominal pressure, strategies for pre-emptive treatment of intraabdominal hypertension, and swift treatment when ACS develops.
The aim of a propensity-matched retrospective cohort study was to investigate whether leaving the abdomen open with delayed closure can improve outcome in terms of mortality and major complications in patients treated for rAAA with open repair, compared to closing the abdomen at the end of the primary operation [118]. In total, 79 patients treated with a primarily open abdomen were compared to a control group of 148 patients. There was no difference in 30-day mortality between patients treated with a primarily open abdomen and the controls, 21 (26.6%) versus 49 (33.1%), p=0.37. No difference was observed between the groups regarding 90-day mortality, postoperative renal failure requiring renal replacement therapy, postoperative intestinal ischaemia necessitating bowel resection or postoperative
152
https://t.me/medicina_free
5 Abdominal Aortic Aneurysm (AAA)
bleeding requiring reoperation. Therefore, this study did not lend support to routine use of open abdomen treatment after surgical rAAA repair.
5.4.6.6 Colonic Ischemia After rAAA Repair
Sigmoidoscopy
Jalalzadeh et al. [119] determined the value of sigmoidoscopy to detect colonic ischaemia (CI) after repair of ruptured abdominal aortic aneurysm. Sigmoidoscopies were carried out based on clinical judgment. Endoscopy results were classied as “no ischaemia,” “mild CI,” or “moderate to severe CI.” In 43 of 351 patients (12%) any grade of CI, as detected by sigmoidoscopy or laparotomy, was diagnosed. The study suggested that the diagnostic value of sigmoidoscopy to detect CI after rAAA repair is high in patients with a clinically moderate suspicion of CI.First, it is effec­tive in ruling out the presence of CI.Second, when doubts exist about the presence of CI, the probability of identifying a patient with transmural ischaemia increases from approximately 22–73% when moderate to severe CI is detected at sigmoidoscopy.
Extraluminal pH Measurement
Postoperative surveillance to detect colonic ischemia using extraluminal pH mea­surement (pHe) was performed by Ersryd etal. [120] in 27 subjects who had under­gone surgery for intact or ruptured abdominal aortic aneurysms. At the end of the primary open AAA repair, before abdominal closure, a balloon catheter was tun­neled through the abdominal wall of the left fossa, lateral to the inferior epigastric artery, and placed in the peritoneal fold adjacent to the sigmoid colon. The balloon was positioned in contact with the sigmoid serosa. The catheter was connected to a Tonocap device (GE Healthcare, Helsinki, Finland), and the pCO2 was measured inside the balloon catheter. Measurements of pHe using colonic tonometry indi­cated malperfusion in all four patients who had developed clinically signicant CI. Extraluminal pH measurement is a promising technique for surveillance of colonic ischemia after open abdominal aortic aneurysm repair, but larger studies are warranted.
References
1. Wanhainen A, Verzini F, Van Herzeele I, et al. Editor’s choice—European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg. 2019;57:8–93. Erratum in: Eur J Vasc Endovasc Surg. 2020;59(3):494.
References
https://t.me/medicina_free
2. Chaikof EL, Dalman RL, Eskandari MK, Jackson BM, Lee WA, Mansour MA, Mastracci TM, Mell M, Murad MH, Nguyen LL, Oderich GS, Patel MS, Schermerhorn ML, Starnes BW. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67:2–77.
3. Isselbacher EM, Preventza O, Hamilton Black J 3rd, etal. 2022 ACC/AHA Guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/ American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022;146:e334–482.
4. Guirguis-Blake JM, Beil TL, Senger CA, Coppola EL.Primary care screening for abdomi­nal aortic aneurysm: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;322:2219–38.
5. Duncan A, Maslen C, Gibson C, Hartshorne T, Farooqi A, Saratzis A, Bown MJ.Ultrasound screening for abdominal aortic aneurysm in high-risk women. Br J Surg. 2021;108:1192–8.
6. Meecham L, Jacomelli J, Davis M, Pherwani A, Lees T, Earnshaw JJ.Outcomes in men from the NHS abdominal aortic aneurysm screening programme with a large aneurysm referred for intervention. Eur J Vasc Endovasc Surg. 2021;61:192–9.
7. Dansey KD, Varkevisser RRB, Swerdlow NJ, Li C, de Guerre LEVM, Liang P, Marcaccio C, O’Donnell TFX, Carroll BJ, Schermerhorn ML.Epidemiology of endovascular and open repair for abdominal aortic aneurysms in the United States from 2004 to 2015 and implica­tions for screening. J Vasc Surg. 2021;74:414–24.
8. Mota L, Marcaccio CL, Dansey KD, de Guerre LEVM, O’Donnell TFX, Soden PA, Zettervall SL, Schermerhorn ML. Overview of screening eligibility in patients undergo­ing ruptured AAA repair from 2003 to 2019in the Vascular Quality Initiative. J Vasc Surg. 2022;75:884–92.
9. Thorbjørnsen K, Svensjö S, Gilgen NP, Wanhainen A.Long term outcome of screen detected sub-aneurysmal aortas in 65 year old men: a single scan after ve years identies those at risk of needing AAA repair. Eur J Vasc Endovasc Surg. 2021;62:380–6.
10. Lederle FA, Kyriakides TC, Stroupe KT, Freischlag JA, Padberg FT Jr, Matsumura JS, Huo Z, Johnson GR, OVER Veterans Affairs Cooperative Study Group. Open versus endovascular repair of abdominal aortic aneurysm. N Engl J Med. 2019;380:2126–35.
11. Sweeting MJ, Patel R, Powell JT, Greenhalgh RM, EVAR Trial Investigators. Endovascular repair of abdominal aortic aneurysm in patients physically ineligible for open repair: very long-term follow-up in the EVAR-2 randomized controlled trial. Ann Surg. 2017;266:713–9.
12. Samura M, Morikage N, Otsuka R, Mizoguchi T, Takeuchi Y, Nagase T, Harada T, Yamashita O, Suehiro K, Hamano K. Endovascular aneurysm repair with inferior mesenteric artery embolization for preventing type II endoleak: a prospective randomized controlled trial. Ann Surg. 2020;271:238–44.
13. Fabre D, Mougin J, Mitilian D, Cochennec F, Garcia Alonso C, Becquemin JP, Desgranges P, Allaire E, Hamdi S, Brenot P, Bourkaib R, Haulon S.Prospective, randomised two centre trial of endovascular repair of abdominal aortic aneurysm with or without sac embolisation. Eur J Vasc Endovasc Surg. 2021;61:201–9.
14. Ulug P, Powell JT, Martinez MA, Ballard DJ, Filardo G.Surgery for small asymptomatic abdominal aortic aneurysms. Cochrane Database Syst Rev. 2020;7(7):CD001835. https://doi.
org/10.1002/14651858.CD001835.
15. Antoniou GA, Antoniou SA, Torella. Editor’s choice—endovascular vs. open repair for abdominal aortic aneurysm: systematic review and meta-analysis of updated peri-operative and long term data of randomised controlled trials. Eur J Vasc Endovasc Surg. 2020;59:385–97.
16. Li B, Khan S, Salata K, Hussain MA, de Mestral C, Greco E, Aljabri BA, Forbes TL, Verma S, Al-Omran M.A systematic review and meta-analysis of the long-term outcomes of endo­vascular versus open repair of abdominal aortic aneurysm. J Vasc Surg. 2019;70:954–69.
17. Bulder RMA, Bastiaannet E, Hamming JF, Lindeman JHN.Meta-analysis of long-term sur­vival after elective endovascular or open repair of abdominal aortic aneurysm. Br J Surg. 2019;106:523–33.
153
154
https://t.me/medicina_free
18. Liu Y, Yang Y, Zhao J, Chen X, Wang J, Ma Y, Huang B, Yuan D, Du X.Systematic review and meta-analysis of sex differences in outcomes after endovascular aneurysm repair for infrarenal abdominal aortic aneurysm. J Vasc Surg. 2020;71:283–96.
19. Pouncey AL, David M, Morris RI, Ulug P, Martin G, Bicknell C, Powell JT.Editor’s choice— systematic review and meta-analysis of sex specic differences in adverse events after open and endovascular intact abdominal aortic aneurysm repair: consistently worse outcomes for women. Eur J Vasc Endovasc Surg. 2021;62:367–78.
20. Wanken ZJ, Barnes JA, Trooboff SW, Columbo JA, Jella TK, Kim DJ, Khoshgowari A, Riblet NBV, Goodney PP.A systematic review and meta-analysis of long-term reintervention after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2020;72:1122–31.
21. Kontopodis N, Galanakis N, Antoniou SA, Tsetis D, Ioannou CV, Veith FJ, Powell JT, Antoniou GA. Meta-analysis and meta-regression analysis of outcomes of endovascu­lar and open repair for ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2020;59:399–410.
22. Kontopodis N, Galanakis N, Ioannou CV, Tsetis D, Becquemin JP, Antoniou GA.Time-to­event data meta-analysis of late outcomes of endovascular versus open repair for ruptured abdominal aortic aneurysms. J Vasc Surg. 2021;74:628–38.
23. Kontopodis N, Galanakis N, Akoumianakis E, Ioannou CV, Tsetis D, Antoniou GA.Editor’s choice—systematic review and meta-analysis of the impact of institutional and surgeon pro­cedure volume on outcomes after ruptured abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2021;62:388–98.
24. Roosendaal LC, Kramer GM, Wiersema AM, Wisselink W, Jongkind V.Outcome of ruptured abdominal aortic aneurysm repair in octogenarians: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2020;59:16–22.
25. Leatherby RJ, Shan MR, Antoniou GA.Editor’s choice—systematic review and meta- analysis of the effect of weekend admission on outcomes for ruptured abdominal aortic aneurysms: a call for an equitable seven day vascular service. Eur J Vasc Endovasc Surg. 2021;61:767–78.
26. Yei K, Mathlouthi A, Naazie I, Elsayed N, Clary B, Malas M.Long-term outcomes associ­ated with open vs endovascular abdominal aortic aneurysm repair in a medicare-matched database. JAMA Netw Open. 2022;5(5):e2212081.
27. Epple J, Svidlova Y, Schmitz-Rixen T, Böckler D, Lingwal N, Grundmann RT, German Institute for Vascular Healthcare Research (DIGG) of the German Society for Vascular Surgery and Vascular Medicine. Long-term outcome of intact abdominal aortic aneurysm after endovascular or open repair. Vasc Endovasc Surg. 2023;57(8):829–37. https://doi.
org/10.1177/15385744231178130.
28. Varkevisser RRB, Carvalho Mota MT, Swerdlow NJ, Stone DH, Scali ST, Blankensteijn JD, Verhagen HJM, Schermerhorn ML.Long-term age-stratied survival following endovascular and open abdominal aortic aneurysm repair. J Vasc Surg. 2022;76:899–907.
29. Columbo JA, Martinez-Camblor P, O’Malley AJ, Suckow BD, Hoel AW, Stone DH, Schanzer A, Schermerhorn ML, Sedrakyan A, Goodney PP, Society for Vascular Surgery’s Vascular Quality Initiative. Long-term reintervention after endovascular abdominal aortic aneurysm repair. Ann Surg. 2021;274:179–85.
30. Columbo JA, Goodney PP, Gladders BH, Tsougranis G, Wanken ZJ, Trooboff SW, Powell RJ, Stone DH.Medicare costs for endovascular abdominal aortic aneurysm treatment in the Vascular Quality Initiative. J Vasc Surg. 2021;73:1056–61.
31. Chang H, Rockman CB, Jacobowitz GR, Ramkhelawon B, Cayne NS, Veith FJ, Patel VI, Garg K. Contemporary outcomes of endovascular abdominal aortic aneurysm repair in patients deemed unt for open surgical repair. J Vasc Surg. 2021;73:1583–92.
32. Roush WP, Behrens M, Smith JB, Kruse RL, Balasundaram N, Vogel TR, Bath J.Outcomes of elective abdominal aortic aneurysm repair in the setting of malignancy. J Vasc Surg. 2022;76:428–36.
5 Abdominal Aortic Aneurysm (AAA)
References
https://t.me/medicina_free
33. Ettengruber A, Epple J, Schmitz-Rixen T, Böckler D, Grundmann RT.Long-term outcome and cancer incidence after abdominal aortic aneurysm repair. Langenbeck’s Arch Surg. 2022;407:3691–9.
34. Brown CS, Montgomery JR, Kim GY, Kemp MT, Osborne NH.Reliability of hospital-level mortality in abdominal aortic aneurysm repair. J Vasc Surg. 2022;75:535–42.
35. Sharma G, Madenci AL, Wanis KN, Comment LA, Lotto CE, Shah SK, Ozaki CK, Subramanian SV, Eldrup-Jorgensen J, Belkin M. Association and interplay of surgeon and hospital volume with mortality after open abdominal aortic aneurysm repair in the modern era. J Vasc Surg. 2021;73:1593–602.
36. Scali ST, Arnaoutakis DJ, Neal D, Giles KA, Goodney PP, Suckow BD, Powell RJ, Columbo JA, Back MR, Berceli SA, Beck AW, Upchurch GR Jr, Huber TS, Stone DH.Association between surgeon case volume and years of practice experience with open abdominal aortic aneurysm repair outcomes. J Vasc Surg. 2021;73:1213–26.
37. Geiger JT, Fleming FJ, Stoner M, Doyle A. Surgeon volume and established hospital peri­operative mortality rate together predict for superior outcomes after open abdominal aortic aneurysm repair. J Vasc Surg. 2022;75:504–13.
38. Scali ST, Suckow BD, Goodney PP, de Guerre LEVM, Schermerhorn ML, Huber TS, Upchurch GR Jr, Neal D, Columbo JA, Kang J, Powell RJ, Stone DH.A signicant propor­tion of current endovascular aortic aneurysm repair practice fails to meet Society for Vascular Surgery clinical practice guideline recommended abdominal aortic aneurysm diameter treat­ment thresholds in the Vascular Quality Initiative. J Vasc Surg. 2022;75:1234–41.
39. Li B, Rizkallah P, Eisenberg N, Forbes TL, Roche-Nagle G.Thresholds for abdominal aortic aneurysm repair in Canada and United States. J Vasc Surg. 2022;75:894–905.
40. von Meijenfeldt GCI, Alberga AJ, Balm R, Vahl AC, Verhagen HJM, Blankensteijn JD, Zeebregts CJ, van der Laan MJ.Results from a nationwide prospective registry on open surgical or endovascular repair of juxtarenal abdominal aortic aneurysms. J Vasc Surg. 2022;75:81–9.
41. Bellamkonda KS, Nassiri N, Sadeghi MM, Zhang Y, Guzman RJ, Ochoa Chaar CI.Characteristics and outcomes of small abdominal aortic aneurysm rupture in the American College of Surgeons National Surgical Quality Improvement Program database. J Vasc Surg. 2021;74:729–37.
42. Varkevisser RRB, Swerdlow NJ, de Guerre LEVM, Dansey K, Stangenberg L, Giles KA, Verhagen HJM, Schermerhorn ML, Society for Vascular Surgery Vascular Quality Initiative. Five-year survival following endovascular repair of ruptured abdominal aortic aneurysms is improving. J Vasc Surg. 2020;72:105–13.
43. Wang LJ, Locham S, Al-Nouri O, Eagleton MJ, Clouse WD, Malas MB.Endovascular repair of ruptured abdominal aortic aneurysm is superior to open repair: propensity-matched analy­sis in the Vascular Quality Initiative. J Vasc Surg. 2020;72:498–507.
44. Khashram M, Williman JA, Hider PN, Jones GT, Roake JA.Management of modiable vas­cular risk factors improves late survival following abdominal aortic aneurysm repair: a sys­tematic review and meta-analysis. Ann Vasc Surg. 2017;39:301–11.
45. Robertson L, Atallah E, Stansby G.Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm. Cochrane Database Syst Rev. 2017;1(1):CD010447.
46. Arinze N, Farber A, Levin SR, Cheng TW, Jones DW, Siracuse CG, Patel VI, Rybin D, Doros G, Siracuse JJ.The effect of the duration of preoperative smoking cessation timing on out­comes after elective open abdominal aortic aneurysm repair and lower extremity bypass. J Vasc Surg. 2019;70:1851–61.
47. Salata K, Syed M, Hussain MA, de Mestral C, Greco E, Mamdani M, Tu JV, Forbes TL, Bhatt DL, Verma S, Al-Omran M.Statins reduce abdominal aortic aneurysm growth, rup­ture, and perioperative mortality: a systematic review and meta-analysis. J Am Heart Assoc. 2018;7:e008657.
155
156
https://t.me/medicina_free
48. Risum Ø, Sandven I, Sundhagen JO, Abdelnoor M.Editor’s choice—effect of statins on total mortality in abdominal aortic aneurysm repair: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2021;61:114–20.
49. Alshaikh HN, Bohsali F, Gani F, Nejim B, Malas M.Statin intensity and postoperative mor­tality following open repair of intact abdominal aortic aneurysm. BJS Open. 2018;2:411–8.
50. O’Donnell TFX, Deery SE, Shean KE, Mittleman MA, Darling JD, Eslami MH, DeMartino RR, Schermerhorn ML.Statin therapy is associated with higher long-term but not periopera­tive survival after abdominal aortic aneurysm repair. J Vasc Surg. 2018;68:392–9.
51. Cameron SJ, Russell HM, Owens AP 3rd. Antithrombotic therapy in abdominal aortic aneu­rysm: benecial or detrimental? Blood. 2018;132:2619–28.
52. Eldrup N, Budtz-Lilly J, Laustsen J, Bibby BM, Paaske WP.Long-term incidence of myo­cardial infarct, stroke, and mortality in patients operated on for abdominal aortic aneurysms. J Vasc Surg. 2012;55:311–7.
53. Wemmelund H, Jørgensen TM, Høgh A, Behr-Rasmussen C, Johnsen SP, Lindholt JS.Low­dose aspirin and rupture of abdominal aortic aneurysm. J Vasc Surg. 2017;65:616–625.e4.
54. Kristensen SD, Knuuti J, Saraste A, etal. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35:2383–431.
55. Hajibandeh S, Hajibandeh S, Antoniou SA, Torella F, Antoniou GA.Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis. Br J Anaesth. 2017;118:11–21.
56. Alshaikh HN, Canner JK, Malas M.Effect of beta blockers on mortality after open repair of abdominal aortic aneurysm. Ann Surg. 2018;267:1185–90.
57. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG.Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795–804.
58. Ultee KH, Rouwet EV, Hoeks SE, van Lier F, Bastos Gonçalves F, Boersma E, Stolker RJ, Verhagen HJ.Coronary revascularization induces a shift from cardiac toward noncardiac mor­tality without improving survival in vascular surgery patients. J Vasc Surg. 2015;61:1543–9.
59. Poldermans D, Schouten O, Vidakovic R, etal. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol. 2007;49:1763–9.
60. Schouten O, van Kuijk JP, Flu WJ, Winkel TA, Welten GM, Boersma E, Verhagen HJ, Bax JJ, Poldermans D, DECREASE Study Group. Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study). Am J Cardiol. 2009;103:897–901.
61. Sonny A, Gornik HL, Yang D, Mascha EJ, Sessler DI.Lack of association between carotid artery stenosis and stroke or myocardial injury after noncardiac surgery in high-risk patients. Anesthesiology. 2014;121:922–9.
62. McGinigle KL, Eldrup-Jorgensen J, McCall R, Freeman NL, Pascarella L, Farber MA, Marston WA, Crowner JR.A systematic review of enhanced recovery after surgery for vas­cular operations. J Vasc Surg. 2019;70:629–40.
63. Malik K, Poletto G, Musto L, Giustiniano E, Cecconi M, Civilini E.Implementation of a perioperative protocol to enhance open aortic repair. J Vasc Surg. 2021;74:434–41.
64. Giacomelli E, Dorigo W, Campolmi M, Casini A, Fargion A, Bush RL, Piffaretti G, Pratesi C.A pilot study of the enhanced recovery after surgery protocol in aortic surgery. J Vasc Surg. 2021;74:90–6.
65. NICE Guideline Updates Team (UK). Anaesthesia and analgesia for people having surgical repair of an abdominal aortic aneurysm: abdominal aortic aneurysm: diagnosis and manage­ment: evidence NICE review L.London: National Institute for Health and Care Excellence (UK); 2020. PMID: 32407029.
5 Abdominal Aortic Aneurysm (AAA)